FMP
Financial data for every need
We provide one of the most accurate financial data available on the market. You can get historical prices, fundamental data, insider transactions, and much more that goes back 30 years in history.
Get started
70,000+ Stocks with tons of data
Ready to Unlock Insights?
Welcome to our comprehensive suite of tools designed to streamline your financial data integration process.
API Documentation
Access user-friendly RESTful API documentation suitable for all skill levels.
Detailed endpoint documentation.
Clear request/response examples.
Streamlined navigation.
Ensures clarity/reliability.
API Viewer
Explore endpoints hassle-free with our code-free API Playground.
Interactive data tools.
User-friendly interface.
Download data in CSV/Excel.
Ideal for hands-on exploration.
Stock Prices
Real-time Prices, Historical Data and Indicators.
Stock Fundamentals
Financial Statements, Key Metrics, Stock Financial Scores and more.
Market News
Stock News, Press Releases and Experts Articles.
Company Information
Company Outlook, Market Capitalization, Company Core Information.
Data is collected only from trusted sources
Quality data is key to making accurate, informed decisions. All our data is licensed and sourced from curated third-party data partners, such as the U.S. Securities and Exchange Commission (SEC), Board of Governors of the Federal Reserve System.
See DocumentationFast, accurate, and developer friendly
We provide one of the most accurate data available on the market. We spent years designing endpoints and made them informative, well-documented, and easy to use.
Our API has over 100 endpoints and we are still growing and adding new endpoints every week. Every endpoint is available in JSON format and most of them also in CSV format.
We also provide on demand custom endpoint available for our enterprise plan.
See documentation
Trusted by 100,000+ customers
Join us and get your API key
Latest News
Stay Updated and Harness the Power of Our API with the Latest News!
Mar 21, 2025 9:00 AM - Rayan Ahmad
VolitionRx Limited's Upcoming Earnings and Innovations in Cancer Diagnostics
VolitionRx Limited (NYSE American: VNRX) is a multi-national epigenetics company known for its innovative cancer diagnostics. The company is set to release its quarterly earnings on March 24, 2025, with analysts predicting an EPS loss of $0.06 and revenue of approximately $545,340. The earnings repo...
Mar 21, 2025 8:04 AM - Davit Kirakosyan
Nike Slumps Over 6% as Weak Q4 Outlook Overshadows Earnings Beat
Nike (NYSE:NKE) shares dropped more than 6% in pre-market today, as a disappointing revenue forecast for the fourth quarter erased initial gains sparked by a stronger-than-expected third-quarter report. The company reported Q3 earnings per share of $0.54 on revenue of $11.27 billion, beating analyst...
Mar 21, 2025 8:02 AM - Davit Kirakosyan
Micron Beats Q2 Estimates, But Mixed Q3 Outlook Pushes Stock Down
Micron Technology (NASDAQ:MU) topped second-quarter expectations, driven by surging demand from data center and consumer markets, but a mixed third-quarter outlook pushed the stock down more than 3% in pre-market today. The memory chipmaker reported Q2 earnings per share of $1.56, beating analyst es...
Mar 21, 2025 7:59 AM - Davit Kirakosyan
Lennar Beats on Q1 Earnings, But Shares Dip 3% on Weak Margin Forecast
Lennar Corporation (NYSE:LEN) posted stronger-than-expected first-quarter results, but shares fell nearly 3% in pre-market today as investors reacted to a disappointing margin outlook for the current quarter. For Q1, the homebuilder reported adjusted earnings per share of $2.14, outpacing analyst ex...
Mar 21, 2025 7:57 AM - Davit Kirakosyan
FedEx Shares Drop 7% After Slashing Outlook Amid Industrial Slowdown and Tariff Concerns
FedEx (NYSE:FDX) shares fell more than 7% in pre-market today after the delivery giant lowered its full-year profit and revenue guidance, citing ongoing headwinds in the U.S. industrial sector and a challenging operating environment. The company now expects adjusted earnings per share between $18 an...
Mar 21, 2025 7:54 AM - Davit Kirakosyan
Needham Reaffirms Buy on Reddit, Sees Upside Despite 40% Pullback
Reddit (NYSE:RDDT) received a reaffirmed Buy rating and $220 price target from Needham analysts, even as the stock has fallen around 40% since its February 12 earnings report. In a recent update, Needham shared a detailed look at shifting investor sentiment throughout Q1 2025, comparing it to previo...
Mar 21, 2025 7:51 AM - Davit Kirakosyan
Barclays Expects Tesla Q1 Deliveries to Miss Expectations
Barclays analysts reaffirmed a $325 price target and Equalweight rating on Tesla (NASDAQ:TSLA), cautioning that the electric vehicle maker’s first-quarter deliveries are likely to come in well below market expectations. After analyzing data from January and February and early trends from March, Barc...
